Cannabis risks becoming a ‘borderline supplement’ unless it evolves, warns Emyria chief by Steve Jones August 18, 2022April 29, 2024 After receiving ethics approval for its phase 3 clinical trial, Emyria chief executive Michael Winlo spoke […]
MCIA to explore insurance for clinical trials at networking event by Steve Jones August 10, 2022April 29, 2024
CBD and Covid: researchers push for more trials amid promising study results by Steve Jones January 25, 2022April 29, 2024
Avecho Biotechnology signs up participants for absorption study by Hannah Adler September 16, 2021April 26, 2024
Leafcann to supply cannabis to Adelaide Uni for cancer study by Steve Jones May 14, 2021April 26, 2024
Cannabis will never be mainstream until we have evidence for drug registration by Steve Jones January 14, 2021April 26, 2024
‘There’s nothing original about cannabis products, we need to focus on innovation’ by Steve Jones November 12, 2020April 26, 2024
